Senator Gold: Thank you for the supplementary question. I do not know the answer as to why — at least anecdotally — there appears to be less of a shortage south of the border than here. My understanding is that Dr. Supriya Sharma, Health Canada’s Chief Medical Advisor, is of the view — and it is indeed confirmed — that the drug shortage is expected to be resolved soon, as manufacturers of these analgesics have significantly increased their production to meet domestic demand. As I mentioned before, I understand that the minister has recently spoken with a number of manufacturers who are committed to maintaining their increased production capacity over the coming months.

I do not want to speculate — that is not helpful — but we do have labelling requirements in Canada. If that is, in fact, one limiting factor for medications that come from outside of the country, I have been told that work will be done in partnership with providers to add information to the labels in both official languages to ensure that patients and caregivers have the information they need to understand the medication they are taking.

I will make some inquiries, senator, and be happy to report back.